News & Updates

Patients with systemic autoimmune rheumatic disease (SARD)-associated interstitial lung disease (ILD) tend to live longer than those with idiopathic pulmonary fibrosis (IPF), reveals a study.

In lung cancer patients receiving immune checkpoint inhibitors (ICIs), survival is not necessarily better when treatment is administered in the morning vs in the afternoon, according to the i-TIMES study.

More than 80 percent of patients with long COVID have obstructive sleep apnoea (OSA), and these patients present with insomnia rather than the classic excessive daytime sleepiness, according to new research.

Borderline personality disorder (BPD) is associated with higher risks of a wide range of physical diseases and increased mortality from all causes, natural causes, and external causes, according to a 16-year population-based cohort study in Hong Kong.

A review of 19 meta-analyses shows mixed results on the effects of multivitamin and mineral (MVM) supplementation on health outcomes.

BTK inhibition with rilzabrutinib does not appear to significantly decrease the incidence of loss-of-asthma-control (LOAC) event compared with placebo in patients with moderate-to-severe asthma with uncontrolled symptoms, according to a phase II study. However, the investigational drug has been associated with meaningful symptom improvements over time, despite withdrawal of background therapy.

People exposed to air pollution for too long are at greater risk of developing rheumatoid arthritis (RA)-associated interstitial lung disease (ILD), with the effect potentially modified according to MUC5B rs35705950 genotype, reveals a study.